Specially, expressions of α7 and α4β2 nAChRs in astrocytes often demonstrate a compensatory increase and overexpression of astrocytic α7 nAChR might serve as an early marker of reactive astrogliosis in patients with AD. The gene discussed is CHRNA7; the disease is Alzheimer disease.